SCHEMBL19919652

SCHEMBL19919652

Cc1cc(-c2cc(-n3c4ccc(-c5cc(C(F)(F)F)cc(C(F)(F)F)c5)cc4c4cc(-c5cc(C(F)(F)F)cc(C(F)(F)F)c5)ccc43)c(C#N)cc2-n2c3ccc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3c3cc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)ccc32)cc(C)n1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
CTSS P25774 2/20 0.33
CTSK P43235 2/20 0.33
AR P10275 3/20 0.33
GRM2 Q14416 2/20 0.32
ICMT O60725 3/20 0.32
XDH P47989 2/20 0.32
RXRA P19793 2/20 0.32
RXRB P28702 1/20 0.32
PSEN1 P49768 2/20 0.31
PSEN2 P49810 2/20 0.31
APH1B Q8WW43 2/20 0.31
NCSTN Q92542 2/20 0.31
APH1A Q96BI3 2/20 0.31
PSENEN Q9NZ42 2/20 0.31
EIF4EBP1 Q13541 1/20 0.31
PGR P06401 1/20 0.31
RXRG P48443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913257 0.95 AR (0.33) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19909386 0.93 CYP11B1 (0.35) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19917977 0.92 CYP11B1 (0.36) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19919645 0.92 METAP2 (0.36) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL23487288 0.91 CYP11B1 (0.34) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19918045 0.91 AR (0.36) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19919643 0.90 METAP2 (0.34) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19912452 0.90 AR (0.36) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19917917 0.89 AR (0.44) CYP11B1CYP11B2CTSSCTSKAR
SCHEMBL19912438 0.88 AR (0.36) CYP11B1CYP11B2ARICMTXDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 CYP11B1 610/4885CYP11B2 402/4885CTSS 3907/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 CYP11B1 1400/4885CYP11B2 965/4885CTSS 4299/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 CYP11B1 610/4885CYP11B2 402/4885CTSS 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.